Human leukocyte antigen compatibility in heart transplantation: Evidence for a differential role of HLA matching on short- and medium-term patient survival

Transplantation

Volumn 63, Issue 9, 1997, Pages 1346-1351

  Taylor, Craig J ^a   Smith, Sheila I ^a   Sharples, Linda D ^b   Parameshwar, Jayan ^b   Cary, Nat R B ^b   Keogan, Mary ^b   Wallwork, John ^b   Large, Stephen R ^b  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN;

ANTIGEN RECOGNITION; ARTICLE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY; HLA SYSTEM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTES; TIME FACTORS;

EID: 0031009051     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199705150-00024     Document Type: Article

References (35)

1. Batchelor JR. The laws of transplantation: a modern perspective. Eye 1995; 9: 152.
2. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1995; 15: 32.
3. Braun MY, McCormach A, Webb G, Batchelor JR. Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by the direct pathway of sensitization. Transplantation 1993; 55: 177.
4. Fangmann J, Dalchau R, Fabre JW. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 1992; 175: 1521.
5. Taylor CJ, Welsh KI, Gray CM, et al. Clinical and socio-economic benefits of serological HLA-DR matching for renal transplantation over three eras of immunosuppression regimens in a single unit. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1993. Los Angeles: UCLA Tissue Typing Laboratory, 1994: 233.
6. Dyer PA, Johnson RWG, Martin S, et al. Evidence that matching for HLA antigens significantly increases transplant survival in 1001 renal transplants performed in the northwest region of England. Transplantation 1989; 48: 131.
7. Aswad S, Mann SL, Khetan U, et al. Omit HLA matching to attain shorter cold ischemia time? Transplant Proc 1993; 25: 3053.
8. Connolly JK, Dyer PA, Martin S, Parrott NR, Pearson RC, Johnson RWG. Importance of minimizing HLA-DR mismatch and cold preservation time in cadaveric renal transplantation. Transplantation 1996; 61: 709.
9. Taylor RJ, Andrews W, Rosenthal JT, Carpenter B, Hakala TR. Influence of DR matching in cadaveric renal transplants performed with cyclosporine. Transplantation 1984; 38: 616.
10. Lundgren G, Groth CG, Albrechtsen D, et al. HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation: a changing picture with cyclosporin. Lancet 1986; 2: 66.
11. Thorogood J, Persijn GG, Schreuder GM, et al. The effect of HLA matching on kidney graft survival in separate posttransplantation intervals. Transplantation 1990; 50: 146.
12. Takemoto S, Terasaki PI, Cecka JM, Cho YW, Gjertson DW, for the UNOS Scientific Renal Transplant Registry. Survival of nationally shared, HLA matched kidney transplants from cadaveric donors. N Engl J Med 1992; 327: 834.
13. Opelz G, Schwarz V, Engelmann A, Back D, Wilk M, Keppel E. Long-term impact of HLA matching on kidney graft survival in cyclosporine treated recipients. Transplant Proc 1991; 23: 373.
14. Starzl TE, Demetris AJ, Trucco M. HLA matching and the point system. Clin Transplant 1993; 7: 353.
15. Guttmann R. The graft survival curve: ideology and rhetoric. Transplant Proc 1992; 24: 2407.
16. Opelz G, Wujciak T, for the Collaborative Transplant Study. The influence of HLA compatibility on graft survival after heart transplantation. N Engl J Med 1994; 330: 819.
17. Morris PJ. HLA matching and cardiac transplantation. N Engl J Med 1994; 330: 857.
18. Sheldon S, Hasleton PS, Yonan NA, et al. Rejection in heart transplantation strongly correlates with HLA-DR antigen mismatch. Transplantation 1994; 58: 719.
19. Smith JD, Rose ML, Pomerance A, Burke M, Yacoub MH. Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching. Lancet 1995; 346: 1318.
20. Zerbe TR, Arena VC, Kormos RL, Griffith BP, Hardesty RL, Duquesnoy RJ. Histocompatibility and other risk factors for histological rejection of human cardiac allografts during the first three months following transplantation. Transplantation 1991; 52: 485.
21. Cochrane A, Benson E, Williams T, Bergin P, Esmore D. Effect of HLA-DR matching on rejection after cardiac transplantation. Transplant Proc 1992; 24: 169.
22. DiSesa VJ, Kuo PC, Horvath KA, Mudge GH, Collins JJ Jr, Cohn LH. HLA histocompatibility affects cardiac transplant rejection and may provide one basis for organ allocation. Ann Thorac Surg 1990; 98: 1113.
23. Raffoux C, Mayor V, Cabrol C, Busson M, Hors J, Colombani J. The influence of HLA matching in cardiac allograft recipients in a single center. Transplant Proc 1987; 19: 3559.
24. Pfeffer PF, Foerster A, Froysaker T, Thorsby E. Correlation between HLA-DR mismatch and rejection episodes in cardiac transplantation. Transplant Proc 1987; 19: 691.
25. Kerman RH, Kimball P, Scheinen S, et al. The relationship among donor-recipient HLA mismatches, rejection and death from coronary artery disease in cardiac transplant recipients. Transplantation 1994; 57: 884.
26. Khaghani A, Yacoub M, McCloskey D, et al. The influence of HLA matching donor/recipient sex, and incidence of acute rejection on survival in cardiac allograft recipients receiving cyclosporin A and azathioprine. Transplant Proc 1989; 21: 799.
27. Taylor CJ, Chapman JR, Ting A, Morris PJ. Characterization of lymphocytotoxic antibodies causing a positive crossmatch in renal transplantation: relationship to primary and regraft outcome. Transplantation 1989; 48: 953.
28. Taylor CJ, Ting A, Morris PJ. Production and characterization of human monoclonal lymphocytotoxic autoantibodies from a renal dialysis patient. Tissue Antigens 1991; 37: 112.
29. White DJG. Immunosuppression for cardiac transplantation. In: Wallwork J, ed. Heart and heart-lung transplantation. Philadelphia: W.B. Saunders, 1989: 155.
30. Terness P, Dufter C, Post S, et al. Heart allograft survival in rats following immunization with soluble peptide MHC class 1 donor antigens: evidence for the role of indirect recognition in rejection. Transpl Int 1994; 7 (suppl 1): S584.
31. Terness P, Dufter C, Otto G, Opelz G. Allograft survival following immunization with membrane-bound or soluble peptide MHC class 1 donor antigens: factors relevant for the induction of rejection by indirect recognition. Transpl Int 1996; 9: 2.
32. Peugh WN, Wood KJ, Shreffler DC, Morris PJ, Morton-Bolman R. The role of individual minor histocompatibility antigens in cardiac allograft rejection. Transplant Proc 1989; 21: 801.
33. Zantvoort FA, D'Amaro J, Persijn G, et al. The impact of HLA-A matching on long-term survival of renal allografts. Transplantation 1996; 61: 841.
34. Donaldson P, Underhill J, Doherty D, et al. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect." Hepatology 1993; 17: 1005.
35. Goulmy E, Schipper R, Pool J, et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334: 281.